Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Narcolepsy-cataplexy].

E Deflandre1, F Roelants, L Cambron

  • 1Service d'Anesthésie-Réanimation, CHU Liège.

Revue Medicale De Liege
|October 31, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Perioperative smoking cessation (conventional smoking and e-cigarettes) in 2023. A narrative review of the literature].

Revue des maladies respiratoires·2024
Same author

[Life-threatening flare of an underlying «paraneoplastic» dermatomyositis in a patient with lung adenocarcinoma treated with anti-PD-1 pembrolizuma].

Revue medicale de Liege·2022
Same author

[The role of biomarkers in the detection of the OSA syndrome. A narrative review of the literature].

Revue des maladies respiratoires·2021
Same author

[Predictive scores used during the anesthetic preoperative visit. Part 2. Assessment of perioperative risk].

Revue medicale de Liege·2021
Same author

[Predictive scores used during the anesthetic preoperative visit. Part 1. Assessment of postoperative complications].

Revue medicale de Liege·2021
Same author

Anaesthesia for patients with obstructive sleep apnoea should be patient-directed and not drug-directed.

Anaesthesia·2020
Same journal

[Nature prescriptions and health promotion : sharing experience from primary care].

Revue medicale de Liege·2026
Same journal

[Eco-health: shared perspectives on primary care practice].

Revue medicale de Liege·2026
Same journal

[The strategic role of primary care in emerging diseases : surveillance, research, and preparedness].

Revue medicale de Liege·2026
Same journal

[Environmental impact of medicines and approaches for more eco responsible use].

Revue medicale de Liege·2026
Same journal

[Climate change and skin].

Revue medicale de Liege·2026
Same journal

[From Silent Spring to neuronal silence : pesticides and neurodegenerative diseases].

Revue medicale de Liege·2026
See all related articles

Narcolepsy-cataplexy diagnosis relies on medical history, polysomnography, and HLA typing. Research suggests hypocretin deficiency may be key, with current therapies managing symptoms like daytime sleepiness and cataplexy.

Area of Science:

  • Neurology
  • Sleep Medicine
  • Immunogenetics

Context:

  • Narcolepsy-cataplexy diagnosis involves a multi-faceted approach.
  • Current understanding points to hypocretin deficiency in narcolepsy pathogenesis.
  • Established diagnostic criteria include clinical evaluation, polysomnography, and HLA typing.

Purpose:

  • To outline the diagnostic framework for narcolepsy-cataplexy.
  • To highlight emerging pathogenetic hypotheses involving hypocretin.
  • To describe the symptomatic nature of current therapeutic interventions.

Summary:

  • Diagnosis integrates medical history (sleep attacks, cataplexy), polysomnography (REM sleep onset), and HLA typing (DR15-DQB1*0602) to confirm or exclude narcolepsy-cataplexy.
  • Pathogenesis is increasingly linked to hypocretin deficiency in cerebrospinal fluid, a neurotransmitter previously associated with appetite regulation.

Related Experiment Videos

  • While not curative, new therapies effectively manage key symptoms such as somnolence, daytime sleepiness, cataplexy, and insomnia.
  • Impact:

    • Provides a clear diagnostic pathway for clinicians managing narcolepsy-cataplexy.
    • Advances understanding of narcolepsy's underlying neurobiology.
    • Offers insights into effective symptomatic management strategies for patients.